0.4700
+0.0130
+(2.84%)
At close: 5:35:01 PM GMT+1
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
--
-28,010.0000
-26,643.0000
-27,665.0000
Investing Cash Flow
--
7,202.0000
-126.0000
157.0000
Financing Cash Flow
--
3,241.0000
39,521.0000
5,396.0000
End Cash Position
--
12,445.0000
30,018.0000
17,234.0000
Capital Expenditure
--
-123.0000
-393.0000
-319.0000
Issuance of Capital Stock
--
--
36,568.0000
--
Repayment of Debt
--
-896.0000
-1,136.0000
-1,447.0000
Repurchase of Capital Stock
--
-124.0000
--
--
Free Cash Flow
--
-28,133.0000
-27,036.0000
-27,984.0000
12/31/2020 - 7/4/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
63E.SG Onward Medical N.V.
6.62
-5.43%
BIOS.BR BioSenic S.A.
0.0043
-4.44%
PH4.F CStone Pharmaceuticals
0.2800
-2.10%
1GDA.F Zevra Therapeutics, Inc.
7.85
+6.08%
471A.F aTyr Pharma, Inc.
3.2800
-4.09%
GYX.F Futura Medical plc
0.3400
-10.99%
CVAC.VI CureVac N.V.
3.7560
+4.16%
HQ1.MU Oruka Therapeutics Inc. R
11.20
-5.08%
2Q5.BE Enochian BioSciences Inc
0.8000
+3.49%
ORN.F Oryzon Genomics S.A.
1.4260
-2.73%